Scientists track blood drug levels to personalize leukemia treatment
NCT ID NCT06030089
Summary
This small study looked at how much of the drug venetoclax stays in patients' blood during treatment for acute myeloid leukemia. Researchers measured drug levels and how it affected cancer cells to understand why treatment works better for some people than others. The goal is to eventually use this information to personalize treatment for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nice
Nice, France
-
Hopital la Conception
Marseille, France
Conditions
Explore the condition pages connected to this study.